English
简体中文
Total: £ 56.28
Published Date: 2025-12-10 | Pages: 112 | Tables: 116 | Consumer Goods
The global market for Anxiety Healthcare Products was valued at US$ 1357 million in the year 2024 and is projected to reach a revised size of US$ 2420 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Anxiety Healthcare Products are non-pharmaceutical consumer wellness products—including dietary supplements, functional beverages, aromatherapy solutions, wearable relaxation and biofeedback devices, cognitive calmness apps, sensory therapies, and stress-relief consumer goods—designed to help reduce symptoms of anxiety, tension, nervousness, and autonomic imbalance through mechanisms such as calming botanicals, neurotransmitter modulation, breath-guidance, mindfulness stimulation, sensory soothing, and behavioral conditioning, positioned for everyday lifestyle use rather than clinical psychiatric treatment.
The Anxiety Healthcare Products industry chain begins upstream with botanical extracts, amino acids, aromatherapy oils, sensory textiles, microelectronics for calming wearables, digital content IP, and packaging inputs, then transitions midstream into nutraceutical formulation, aromatherapy blending, wearable hardware design, app development, certification, branding, and contract manufacturing, and finally moves downstream through pharmacies, supermarkets, online D2C subscription platforms, wellness retailers, employers, mental-wellness service partners, and end users seeking natural, non-pharmaceutical, accessible anxiety management solutions that complement lifestyle routines, emotional regulation, sleep improvement, and stress-reduction behaviors.
Current and planned projects include expansion of adaptogen and GABA-based supplement lines, launch of anxiety-plus-sleep and anxiety-plus-focus combination formulations, scaling of aromatherapy delivery systems with smart diffusers, development of wearable biofeedback devices linked to HRV and breathing guidance apps, corporate wellness integration platforms, plant-based functional calming beverages with clean labels, clinical-style consumer validation programs for emotional wellness claims, subscription-based personalization leveraging stress scoring, geographic expansion across North America, Europe, and Asia, and retailer private-label lines offering lower-cost anxiety-relief products with higher gross margins than branded equivalents.
2024 Global Market Average Gross Profit Margin: 45%.
North American market for Anxiety Healthcare Products is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anxiety Healthcare Products is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Anxiety Healthcare Products in Workers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Anxiety Healthcare Products include Unilever – Olly, Otsuka Pharmaceutical, GSK, NOW Foods, Blackmores, Swisse (H&H Group), Herbalife Nutrition, Amway, Life Extension, Gaia Herbs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anxiety Healthcare Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anxiety Healthcare Products.
The Anxiety Healthcare Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anxiety Healthcare Products market comprehensively. Regional market sizes, concerning products by Type, by End User, by Distribution Channel and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anxiety Healthcare Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
Market Segmentation
By Company
Unilever – Olly
Otsuka Pharmaceutical
GSK
NOW Foods
Blackmores
Swisse (H&H Group)
Herbalife Nutrition
Amway
Life Extension
Gaia Herbs
Vitafusion / Church & Dwight
Headspace
Apollo Neuro
Segment by Type
Dietary Supplements
Functional Beverages
Wearables
Others
Segment by Distribution Channel
Pharmacies and Drugstores
Supermarkets and Mass Retail
Health and Wellness Specialty Stores
Online
Segment by Mechanism of Action
Adaptogens
Neurotransmitter-Modulating
ANS Regulation
Sensory Soothing
Others
Segment by End User
Workers
Students
Athletes
Seniors
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by End User, by Distribution Channel etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anxiety Healthcare Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anxiety Healthcare Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Dietary Supplements
1.2.3 Functional Beverages
1.2.4 Wearables
1.2.5 Others
1.3 Market by Distribution Channel
1.3.1 Global Anxiety Healthcare Products Market Size Growth Rate by Distribution Channel: 2020 VS 2024 VS 2031
1.3.2 Pharmacies and Drugstores
1.3.3 Supermarkets and Mass Retail
1.3.4 Health and Wellness Specialty Stores
1.3.5 Online
1.4 Market by Mechanism of Action
1.4.1 Global Anxiety Healthcare Products Market Size Growth Rate by Mechanism of Action: 2020 VS 2024 VS 2031
1.4.2 Adaptogens
1.4.3 Neurotransmitter-Modulating
1.4.4 ANS Regulation
1.4.5 Sensory Soothing
1.4.6 Others
1.5 Market by End User
1.5.1 Global Anxiety Healthcare Products Market Growth by End User: 2020 VS 2024 VS 2031
1.5.2 Workers
1.5.3 Students
1.5.4 Athletes
1.5.5 Seniors
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Anxiety Healthcare Products Market Perspective (2020-2031)
2.2 Global Anxiety Healthcare Products Growth Trends by Region
2.2.1 Global Anxiety Healthcare Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anxiety Healthcare Products Historic Market Size by Region (2020-2025)
2.2.3 Anxiety Healthcare Products Forecasted Market Size by Region (2026-2031)
2.3 Anxiety Healthcare Products Market Dynamics
2.3.1 Anxiety Healthcare Products Industry Trends
2.3.2 Anxiety Healthcare Products Market Drivers
2.3.3 Anxiety Healthcare Products Market Challenges
2.3.4 Anxiety Healthcare Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anxiety Healthcare Products Players by Revenue
3.1.1 Global Top Anxiety Healthcare Products Players by Revenue (2020-2025)
3.1.2 Global Anxiety Healthcare Products Revenue Market Share by Players (2020-2025)
3.2 Global Top Anxiety Healthcare Products Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anxiety Healthcare Products Revenue
3.4 Global Anxiety Healthcare Products Market Concentration Ratio
3.4.1 Global Anxiety Healthcare Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anxiety Healthcare Products Revenue in 2024
3.5 Global Key Players of Anxiety Healthcare Products Head office and Area Served
3.6 Global Key Players of Anxiety Healthcare Products, Product and Application
3.7 Global Key Players of Anxiety Healthcare Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anxiety Healthcare Products Breakdown Data by Type
4.1 Global Anxiety Healthcare Products Historic Market Size by Type (2020-2025)
4.2 Global Anxiety Healthcare Products Forecasted Market Size by Type (2026-2031)
5 Anxiety Healthcare Products Breakdown Data by End User
5.1 Global Anxiety Healthcare Products Historic Market Size by End User (2020-2025)
5.2 Global Anxiety Healthcare Products Forecasted Market Size by End User (2026-2031)
6 North America
6.1 North America Anxiety Healthcare Products Market Size (2020-2031)
6.2 North America Anxiety Healthcare Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anxiety Healthcare Products Market Size by Country (2020-2025)
6.4 North America Anxiety Healthcare Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anxiety Healthcare Products Market Size (2020-2031)
7.2 Europe Anxiety Healthcare Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anxiety Healthcare Products Market Size by Country (2020-2025)
7.4 Europe Anxiety Healthcare Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Anxiety Healthcare Products Market Size (2020-2031)
8.2 Asia-Pacific Anxiety Healthcare Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anxiety Healthcare Products Market Size by Region (2020-2025)
8.4 Asia-Pacific Anxiety Healthcare Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Anxiety Healthcare Products Market Size (2020-2031)
9.2 Latin America Anxiety Healthcare Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anxiety Healthcare Products Market Size by Country (2020-2025)
9.4 Latin America Anxiety Healthcare Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anxiety Healthcare Products Market Size (2020-2031)
10.2 Middle East & Africa Anxiety Healthcare Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anxiety Healthcare Products Market Size by Country (2020-2025)
10.4 Middle East & Africa Anxiety Healthcare Products Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Unilever – Olly
11.1.1 Unilever – Olly Company Details
11.1.2 Unilever – Olly Business Overview
11.1.3 Unilever – Olly Anxiety Healthcare Products Introduction
11.1.4 Unilever – Olly Revenue in Anxiety Healthcare Products Business (2020-2025)
11.1.5 Unilever – Olly Recent Development
11.2 Otsuka Pharmaceutical
11.2.1 Otsuka Pharmaceutical Company Details
11.2.2 Otsuka Pharmaceutical Business Overview
11.2.3 Otsuka Pharmaceutical Anxiety Healthcare Products Introduction
11.2.4 Otsuka Pharmaceutical Revenue in Anxiety Healthcare Products Business (2020-2025)
11.2.5 Otsuka Pharmaceutical Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Anxiety Healthcare Products Introduction
11.3.4 GSK Revenue in Anxiety Healthcare Products Business (2020-2025)
11.3.5 GSK Recent Development
11.4 NOW Foods
11.4.1 NOW Foods Company Details
11.4.2 NOW Foods Business Overview
11.4.3 NOW Foods Anxiety Healthcare Products Introduction
11.4.4 NOW Foods Revenue in Anxiety Healthcare Products Business (2020-2025)
11.4.5 NOW Foods Recent Development
11.5 Blackmores
11.5.1 Blackmores Company Details
11.5.2 Blackmores Business Overview
11.5.3 Blackmores Anxiety Healthcare Products Introduction
11.5.4 Blackmores Revenue in Anxiety Healthcare Products Business (2020-2025)
11.5.5 Blackmores Recent Development
11.6 Swisse (H&H Group)
11.6.1 Swisse (H&H Group) Company Details
11.6.2 Swisse (H&H Group) Business Overview
11.6.3 Swisse (H&H Group) Anxiety Healthcare Products Introduction
11.6.4 Swisse (H&H Group) Revenue in Anxiety Healthcare Products Business (2020-2025)
11.6.5 Swisse (H&H Group) Recent Development
11.7 Herbalife Nutrition
11.7.1 Herbalife Nutrition Company Details
11.7.2 Herbalife Nutrition Business Overview
11.7.3 Herbalife Nutrition Anxiety Healthcare Products Introduction
11.7.4 Herbalife Nutrition Revenue in Anxiety Healthcare Products Business (2020-2025)
11.7.5 Herbalife Nutrition Recent Development
11.8 Amway
11.8.1 Amway Company Details
11.8.2 Amway Business Overview
11.8.3 Amway Anxiety Healthcare Products Introduction
11.8.4 Amway Revenue in Anxiety Healthcare Products Business (2020-2025)
11.8.5 Amway Recent Development
11.9 Life Extension
11.9.1 Life Extension Company Details
11.9.2 Life Extension Business Overview
11.9.3 Life Extension Anxiety Healthcare Products Introduction
11.9.4 Life Extension Revenue in Anxiety Healthcare Products Business (2020-2025)
11.9.5 Life Extension Recent Development
11.10 Gaia Herbs
11.10.1 Gaia Herbs Company Details
11.10.2 Gaia Herbs Business Overview
11.10.3 Gaia Herbs Anxiety Healthcare Products Introduction
11.10.4 Gaia Herbs Revenue in Anxiety Healthcare Products Business (2020-2025)
11.10.5 Gaia Herbs Recent Development
11.11 Vitafusion / Church & Dwight
11.11.1 Vitafusion / Church & Dwight Company Details
11.11.2 Vitafusion / Church & Dwight Business Overview
11.11.3 Vitafusion / Church & Dwight Anxiety Healthcare Products Introduction
11.11.4 Vitafusion / Church & Dwight Revenue in Anxiety Healthcare Products Business (2020-2025)
11.11.5 Vitafusion / Church & Dwight Recent Development
11.12 Headspace
11.12.1 Headspace Company Details
11.12.2 Headspace Business Overview
11.12.3 Headspace Anxiety Healthcare Products Introduction
11.12.4 Headspace Revenue in Anxiety Healthcare Products Business (2020-2025)
11.12.5 Headspace Recent Development
11.13 Apollo Neuro
11.13.1 Apollo Neuro Company Details
11.13.2 Apollo Neuro Business Overview
11.13.3 Apollo Neuro Anxiety Healthcare Products Introduction
11.13.4 Apollo Neuro Revenue in Anxiety Healthcare Products Business (2020-2025)
11.13.5 Apollo Neuro Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anxiety Healthcare Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Dietary Supplements
Table 3. Key Players of Functional Beverages
Table 4. Key Players of Wearables
Table 5. Key Players of Others
Table 6. Global Anxiety Healthcare Products Market Size Growth Rate by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031
Table 7. Key Players of Pharmacies and Drugstores
Table 8. Key Players of Supermarkets and Mass Retail
Table 9. Key Players of Health and Wellness Specialty Stores
Table 10. Key Players of Online
Table 11. Global Anxiety Healthcare Products Market Size Growth Rate by Mechanism of Action (US$ Million): 2020 VS 2024 VS 2031
Table 12. Key Players of Adaptogens
Table 13. Key Players of Neurotransmitter-Modulating
Table 14. Key Players of ANS Regulation
Table 15. Key Players of Sensory Soothing
Table 16. Key Players of Others
Table 17. Global Anxiety Healthcare Products Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Anxiety Healthcare Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Anxiety Healthcare Products Market Size by Region (2020-2025) & (US$ Million)
Table 20. Global Anxiety Healthcare Products Market Share by Region (2020-2025)
Table 21. Global Anxiety Healthcare Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 22. Global Anxiety Healthcare Products Market Share by Region (2026-2031)
Table 23. Anxiety Healthcare Products Market Trends
Table 24. Anxiety Healthcare Products Market Drivers
Table 25. Anxiety Healthcare Products Market Challenges
Table 26. Anxiety Healthcare Products Market Restraints
Table 27. Global Anxiety Healthcare Products Revenue by Players (2020-2025) & (US$ Million)
Table 28. Global Anxiety Healthcare Products Market Share by Players (2020-2025)
Table 29. Global Top Anxiety Healthcare Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anxiety Healthcare Products as of 2024)
Table 30. Ranking of Global Top Anxiety Healthcare Products Companies by Revenue (US$ Million) in 2024
Table 31. Global 5 Largest Players Market Share by Anxiety Healthcare Products Revenue (CR5 and HHI) & (2020-2025)
Table 32. Global Key Players of Anxiety Healthcare Products, Headquarters and Area Served
Table 33. Global Key Players of Anxiety Healthcare Products, Product and Application
Table 34. Global Key Players of Anxiety Healthcare Products, Date of Enter into This Industry
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Anxiety Healthcare Products Market Size by Type (2020-2025) & (US$ Million)
Table 37. Global Anxiety Healthcare Products Revenue Market Share by Type (2020-2025)
Table 38. Global Anxiety Healthcare Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 39. Global Anxiety Healthcare Products Revenue Market Share by Type (2026-2031)
Table 40. Global Anxiety Healthcare Products Market Size by End User (2020-2025) & (US$ Million)
Table 41. Global Anxiety Healthcare Products Revenue Market Share by End User (2020-2025)
Table 42. Global Anxiety Healthcare Products Forecasted Market Size by End User (2026-2031) & (US$ Million)
Table 43. Global Anxiety Healthcare Products Revenue Market Share by End User (2026-2031)
Table 44. North America Anxiety Healthcare Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. North America Anxiety Healthcare Products Market Size by Country (2020-2025) & (US$ Million)
Table 46. North America Anxiety Healthcare Products Market Size by Country (2026-2031) & (US$ Million)
Table 47. Europe Anxiety Healthcare Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Europe Anxiety Healthcare Products Market Size by Country (2020-2025) & (US$ Million)
Table 49. Europe Anxiety Healthcare Products Market Size by Country (2026-2031) & (US$ Million)
Table 50. Asia-Pacific Anxiety Healthcare Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 51. Asia-Pacific Anxiety Healthcare Products Market Size by Region (2020-2025) & (US$ Million)
Table 52. Asia-Pacific Anxiety Healthcare Products Market Size by Region (2026-2031) & (US$ Million)
Table 53. Latin America Anxiety Healthcare Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 54. Latin America Anxiety Healthcare Products Market Size by Country (2020-2025) & (US$ Million)
Table 55. Latin America Anxiety Healthcare Products Market Size by Country (2026-2031) & (US$ Million)
Table 56. Middle East & Africa Anxiety Healthcare Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 57. Middle East & Africa Anxiety Healthcare Products Market Size by Country (2020-2025) & (US$ Million)
Table 58. Middle East & Africa Anxiety Healthcare Products Market Size by Country (2026-2031) & (US$ Million)
Table 59. Unilever – Olly Company Details
Table 60. Unilever – Olly Business Overview
Table 61. Unilever – Olly Anxiety Healthcare Products Product
Table 62. Unilever – Olly Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 63. Unilever – Olly Recent Development
Table 64. Otsuka Pharmaceutical Company Details
Table 65. Otsuka Pharmaceutical Business Overview
Table 66. Otsuka Pharmaceutical Anxiety Healthcare Products Product
Table 67. Otsuka Pharmaceutical Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 68. Otsuka Pharmaceutical Recent Development
Table 69. GSK Company Details
Table 70. GSK Business Overview
Table 71. GSK Anxiety Healthcare Products Product
Table 72. GSK Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 73. GSK Recent Development
Table 74. NOW Foods Company Details
Table 75. NOW Foods Business Overview
Table 76. NOW Foods Anxiety Healthcare Products Product
Table 77. NOW Foods Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 78. NOW Foods Recent Development
Table 79. Blackmores Company Details
Table 80. Blackmores Business Overview
Table 81. Blackmores Anxiety Healthcare Products Product
Table 82. Blackmores Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 83. Blackmores Recent Development
Table 84. Swisse (H&H Group) Company Details
Table 85. Swisse (H&H Group) Business Overview
Table 86. Swisse (H&H Group) Anxiety Healthcare Products Product
Table 87. Swisse (H&H Group) Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 88. Swisse (H&H Group) Recent Development
Table 89. Herbalife Nutrition Company Details
Table 90. Herbalife Nutrition Business Overview
Table 91. Herbalife Nutrition Anxiety Healthcare Products Product
Table 92. Herbalife Nutrition Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 93. Herbalife Nutrition Recent Development
Table 94. Amway Company Details
Table 95. Amway Business Overview
Table 96. Amway Anxiety Healthcare Products Product
Table 97. Amway Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 98. Amway Recent Development
Table 99. Life Extension Company Details
Table 100. Life Extension Business Overview
Table 101. Life Extension Anxiety Healthcare Products Product
Table 102. Life Extension Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 103. Life Extension Recent Development
Table 104. Gaia Herbs Company Details
Table 105. Gaia Herbs Business Overview
Table 106. Gaia Herbs Anxiety Healthcare Products Product
Table 107. Gaia Herbs Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 108. Gaia Herbs Recent Development
Table 109. Vitafusion / Church & Dwight Company Details
Table 110. Vitafusion / Church & Dwight Business Overview
Table 111. Vitafusion / Church & Dwight Anxiety Healthcare Products Product
Table 112. Vitafusion / Church & Dwight Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 113. Vitafusion / Church & Dwight Recent Development
Table 114. Headspace Company Details
Table 115. Headspace Business Overview
Table 116. Headspace Anxiety Healthcare Products Product
Table 117. Headspace Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 118. Headspace Recent Development
Table 119. Apollo Neuro Company Details
Table 120. Apollo Neuro Business Overview
Table 121. Apollo Neuro Anxiety Healthcare Products Product
Table 122. Apollo Neuro Revenue in Anxiety Healthcare Products Business (2020-2025) & (US$ Million)
Table 123. Apollo Neuro Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Anxiety Healthcare Products Picture
Figure 2. Global Anxiety Healthcare Products Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anxiety Healthcare Products Market Share by Type: 2024 VS 2031
Figure 4. Dietary Supplements Features
Figure 5. Functional Beverages Features
Figure 6. Wearables Features
Figure 7. Others Features
Figure 8. Global Anxiety Healthcare Products Market Size Comparison by Distribution Channel (2020-2031) & (US$ Million)
Figure 9. Pharmacies and Drugstores Features
Figure 10. Supermarkets and Mass Retail Features
Figure 11. Health and Wellness Specialty Stores Features
Figure 12. Online Features
Figure 13. Global Anxiety Healthcare Products Market Size Comparison by Mechanism of Action (2020-2031) & (US$ Million)
Figure 14. Adaptogens Features
Figure 15. Neurotransmitter-Modulating Features
Figure 16. ANS Regulation Features
Figure 17. Sensory Soothing Features
Figure 18. Others Features
Figure 19. Global Anxiety Healthcare Products Market Size by End User (2020-2031) & (US$ Million)
Figure 20. Global Anxiety Healthcare Products Market Share by End User: 2024 VS 2031
Figure 21. Workers Case Studies
Figure 22. Students Case Studies
Figure 23. Athletes Case Studies
Figure 24. Seniors Case Studies
Figure 25. Others Case Studies
Figure 26. Anxiety Healthcare Products Report Years Considered
Figure 27. Global Anxiety Healthcare Products Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 28. Global Anxiety Healthcare Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 29. Global Anxiety Healthcare Products Market Share by Region: 2024 VS 2031
Figure 30. Global Anxiety Healthcare Products Market Share by Players in 2024
Figure 31. Global Anxiety Healthcare Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 32. The Top 10 and 5 Players Market Share by Anxiety Healthcare Products Revenue in 2024
Figure 33. North America Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. North America Anxiety Healthcare Products Market Share by Country (2020-2031)
Figure 35. United States Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Canada Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Europe Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Europe Anxiety Healthcare Products Market Share by Country (2020-2031)
Figure 39. Germany Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. France Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. U.K. Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Italy Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Russia Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Ireland Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Asia-Pacific Anxiety Healthcare Products Market Share by Region (2020-2031)
Figure 47. China Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Japan Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. South Korea Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Southeast Asia Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. India Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Australia & New Zealand Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Latin America Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Latin America Anxiety Healthcare Products Market Share by Country (2020-2031)
Figure 55. Mexico Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Brazil Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Middle East & Africa Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Middle East & Africa Anxiety Healthcare Products Market Share by Country (2020-2031)
Figure 59. Israel Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 60. Saudi Arabia Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 61. UAE Anxiety Healthcare Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 62. Unilever – Olly Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 63. Otsuka Pharmaceutical Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 64. GSK Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 65. NOW Foods Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 66. Blackmores Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 67. Swisse (H&H Group) Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 68. Herbalife Nutrition Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 69. Amway Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 70. Life Extension Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 71. Gaia Herbs Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 72. Vitafusion / Church & Dwight Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 73. Headspace Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 74. Apollo Neuro Revenue Growth Rate in Anxiety Healthcare Products Business (2020-2025)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
